Internal Tandem Duplication

What Internal Tandem Duplication Means

Internal Tandem Duplication, often called ITD, is a genetic change where a small section of DNA within a gene is copied and inserted right after the original sequence. This duplication changes the gene’s instructions and can affect how the protein made from that gene works. In cancer, such changes can cause cells to grow and divide abnormally.

Why ITD Matters in Cancer Care

ITD is especially important in certain blood cancers like acute myeloid leukemia (AML). When ITD happens in the FLT3 gene—a gene that helps control blood cell growth—it can make the leukemia more aggressive and harder to treat. Because of this, doctors often test for FLT3-ITD mutations to better understand the cancer and decide on the best treatment options. Some newer drugs specifically target this mutation to help control the disease.

What Patients Might See or Hear About ITD

You might see ITD mentioned in your lab reports, treatment plans, or drug information. It may also appear as “internal tandem duplication” or simply “ITD.” You could hear about it when your care team discusses genetic testing results or treatment options, especially if your leukemia has this mutation. Medicines like quizartinib (Vanflyta), midostaurin, and gilteritinib (Xospata) are examples of treatments that target FLT3-ITD positive AML.

Where ITD Appears in Medical Care

ITD is usually found through specialized genetic tests on leukemia cells. It may be listed in pathology reports, molecular testing results, or clinical trial descriptions. Because it influences treatment choices, your healthcare providers may explain how ITD affects your care plan or eligibility for certain therapies.

What ITD Does Not Automatically Mean

Seeing ITD mentioned does not mean you have a specific diagnosis by itself or that a particular treatment is guaranteed. Not all AML patients have this mutation, and even if they do, treatment depends on many factors like overall health and other genetic changes. ITD is one piece of information doctors use to understand the cancer better.

Common Confusions and How to Ask Questions

ITD can be confused with other uses of the abbreviation or with other genetic terms. It’s helpful to compare wording in reports and ask your care team what ITD means in your exact case. Questions you might ask include: What does my ITD test result mean? How does it affect my treatment options? Are there targeted therapies available for my cancer?

Reading ITD in Context

Because ITD relates to a specific gene mutation, it’s important to understand it as part of your overall diagnosis and treatment plan. Don’t treat the term alone as a diagnosis or a treatment recommendation. Always discuss with your healthcare team how ITD fits into your personal care.

Safety and Next Steps

This information is educational and does not replace medical advice. If ITD appears in your medical records or discussions, the best next step is to ask your care team what it means for your situation. They can explain how it affects your diagnosis, treatment options, and prognosis. Understanding ITD can help you be more informed and involved in your care decisions.